Summary
Fibrillation threshold and heart rate were measured after increasing doses of (−)-isoprenaline and (±)-salbutamol. The initial values of 212±10 μA (x±SEM) and 211±10 μA were decreased to 74±10 μA by low doses of (−)-isoprenaline (10−11 to 10−10 moles/kg i.v.), and to 89±11 μA by (±)-salbutamol (10−9 to 10−8 moles/kg i.v.). Higher doses, paradoxically, increased fibrillation threshold to initial values, (−)-isoprenaline: 2×10−9 moles/kg; (±)-salbutamol: 2×10−6 moles/kg. A linear increase in heart rate per 10-fold increase of either drug was observed, (−)-isoprenaline: 25 beats·min−1; (±)-salbutamol: 14 beats·min−1. The apparent β2-selective property of salbutamol is documented by its low potency in changing fibrillation threshold and heart rate.
References
Brittain, R. T., Farmer, J. B., Marshall, R. J.: Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol. Brit. J. Pharmacol. 48, 144–147 (1973)
Daly, M. J., Farmer, J. B., Levy, G. P.: Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Brit. J. Pharmacol. 43, 624–638 (1971)
Farmer, J. B., Levy, G. P., Marshall, R. J.: A comparison of the β-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline. J. Pharm. Pharmacol. 22, 945–947 (1970)
Fogelman, F., Grundy, H. F.: A comparison of the cardiovascular actions of AQ 110 with those of isoprenaline and salbutamol. Brit. J. Pharmacol. 38, 416–432 (1970)
Giles, R. E., Williams, J. C., Finkel, M. P.: The bronchodilator and cardiac stimulant effects of Th 1165a, salbutamol and isoproterenol. J. Pharmacol. exp. Ther. 186, 472–481 (1973)
Hellenbrecht, D., Lemmer, B., Wiethold, G., Grobecker, H.: Measurement of hydrophobicity, surface activity, local anaesthesia and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine β-adrenergic blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 211–226 (1973)
Hinds, L., Katz, R. L.: Dissociation of tracheobronchial and cardiac effects of some beta-adrenergic stimulants. Anesthesiology 34, 445–449 (1971)
Katz, R. L.: Effects of alpha- and beta-adrenergic blocking agents on cyclopropanecatecholamine cardiac arrhythmias. Anesthesiology 26, 289–298 (1965)
Kirsch, U.: Bestimmung der Flimmerschwelle des Meerschweinchenherzens bei Spontanatmung mittels einer intracardialen Elektrode. Arzneimittel-Forsch. (Drug Res.) 19, 225–228 (1969)
Nayler, W. G., McInnes, I.: Salbutamol and orciprenaline-induced changes in myocardial function. Cardiovasc. Res. 6, 725–733 (1972)
Szekeres, L., Papp, Gy. J.: Experimental cardiac arrhythmias and antiarrhythmic drugs. Budapest; Akadémiai kiadó 1971
Wardell, J. R. Jr., Collella, D. F., Shetzline, A., Fowler, P. J.: Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent. J. Pharmacol. exp. Ther. 189, 167–184 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hellenbrecht, D., Gortner, L. Influence of isoprenaline and salbutamol on the threshold of electrically inuced ventricular fibrillation in anaesthetized guinea pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 227–232 (1975). https://doi.org/10.1007/BF00510454
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510454